Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹3,272.50
Market cap: ₹26,792 Cr
Revenue (annual): ₹1,339 Cr
Net profit (annual): ₹356.3 Cr
P/E (TTM): 69.4×Sector 50.4×
Promoter holding: 32.66%+0.00% QoQ
FII holding: 21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 2 Patent 1 Merger & Restructuring 1 Management Change 1 Capacity Expansion 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Jul 2026 12:32 IST BSE

Financial Results

Acutaas Chemicals Q1 FY27 Results: Net Profit ₹75 Cr, Up 70.5% YoY

Acutaas Chemicals Ltd reported revenue from operations of ₹329.7 Cr (+59.1% YoY) and net profit of ₹75 Cr (+70.5% YoY) for Q1 FY27.

Key figure: Net profit ₹75 Cr · +70.5% YoY

Open full results → Read the filing ↗

30 Apr 2026 12:23 IST BSE

Financial ResultsAlfa Alert

Acutaas Chemicals Q4 FY26 Results: Net Profit ₹134.3 Cr, Up 114.2% YoY

Acutaas Chemicals Ltd reported revenue from operations of ₹432.8 Cr (+40.3% YoY) and net profit of ₹134.3 Cr (+114.2% YoY) for Q4 FY26.

Key figure: Net profit ₹134.3 Cr · +114.2% YoY

Open full results → Read the filing ↗